Search

Your search keyword '"Legarda I"' showing total 123 results

Search Constraints

Start Over You searched for: Author "Legarda I" Remove constraint Author: "Legarda I"
123 results on '"Legarda I"'

Search Results

1. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

2. Management of Parkinson’s disease and other movement disorders in women of childbearing age: Part 2

3. Management of Parkinson’s disease and other movement disorders in women of childbearing age: Part 1

4. Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad fértil: parte 2

5. Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad fértil: Parte 1

6. Depression is Associated with Impulse-compulsive Behaviors in Parkinson’s disease

7. Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression

8. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

9. Supplemental Material, sj-doc-1-jgp-10.1177_0891988720964250 - Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease

10. Supplemental Material, sj-pdf-2-jgp-10.1177_0891988720964250 - Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease

11. Supplemental Material, sj-pdf-1-jgp-10.1177_0891988720964250 - Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease

12. Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life

14. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group

15. MNCD: A New Tool for Classifying Parkinson ' s Disease in Daily Clinical Practice

16. Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

17. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

19. Predictors of clinically significant quality of life impairment in Parkinson's disease

20. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

21. Mood in Parkinson's disease: From early- to late-stage disease

22. Predictors of clinically significant quality of life impairment in Parkinson's disease

23. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial

24. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

25. Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad fértil: parte 2

26. Supplemental Material, Table.2.SM.Sleep.Problems.PD.COPPADIS - Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease

27. Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease

28. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

29. Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease

30. Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease.

31. High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson's disease patients

32. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

33. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

34. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

35. COPPADIS‐2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.

36. Suicidal ideation in a European Huntington's disease population

37. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

38. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

39. NMDA receptor gene variations as modifiers in Huntington disease: a replication study

40. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

41. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

45. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

46. NMDA receptor gene variations as modifiers in Huntington disease

Catalog

Books, media, physical & digital resources